Terms: = Lymphoma AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Diagnosis
7 results:
1. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
2. Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.
Flerlage JE; Myers JR; Maciaszek JL; Oak N; Rashkin SR; Hui Y; Wang YD; Chen W; Wu G; Chang TC; Hamilton K; Tithi SS; Goldin LR; Rotunno M; Caporaso N; Vogt A; Flamish D; Wyatt K; Liu J; Tucker M; Hahn CN; Brown AL; Scott HS; Mullighan C; Nichols KE; Metzger ML; McMaster ML; Yang JJ; Rampersaud E
Blood; 2023 Mar; 141(11):1293-1307. PubMed ID: 35977101
[TBL] [Abstract] [Full Text] [Related]
3. Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia.
Andrés-Jensen L; Grell K; Rank CU; Albertsen BK; Tuckuviene R; Linnemann Nielsen R; Lynggaard LS; Jarvis KB; Quist-Paulsen P; Trakymiene SS; Semaškevičienė R; Saks K; Jonsson OG; Frandsen TL; Johansson PI; Schmiegelow K
Leukemia; 2022 Feb; 36(2):361-369. PubMed ID: 34389803
[TBL] [Abstract] [Full Text] [Related]
4. MiR-139-5p regulates vegfr and downstream signaling pathways to inhibit the development of esophageal cancer.
Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
[TBL] [Abstract] [Full Text] [Related]
5. Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN).
Launay-Vacher V; Aapro M; De Castro G; Cohen E; Deray G; Dooley M; Humphreys B; Lichtman S; Rey J; Scotté F; Wildiers H; Sprangers B
Ann Oncol; 2015 Aug; 26(8):1677-84. PubMed ID: 25735315
[TBL] [Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors.
Miettinen M; Rikala MS; Rys J; Lasota J; Wang ZF
Am J Surg Pathol; 2012 Apr; 36(4):629-39. PubMed ID: 22314185
[TBL] [Abstract] [Full Text] [Related]
7. Expression of VEGF-C, VEGF-D and their receptor vegfr-3 in diffuse large B-cell lymphomas.
Pazgal I; Boycov O; Shpilberg O; Okon E; Bairey O
Leuk Lymphoma; 2007 Nov; 48(11):2213-20. PubMed ID: 17926187
[TBL] [Abstract] [Full Text] [Related]
